We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of VIB7734 for the Treatment of Moderate to Severely Active SLE (RECAST SLE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04925934
Recruitment Status : Active, not recruiting
First Posted : June 14, 2021
Last Update Posted : January 12, 2023
Sponsor:
Information provided by (Responsible Party):
Viela Bio (acquired by Horizon Therapeutics)

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : July 1, 2023
Estimated Study Completion Date : October 1, 2023